Antibotulinum serum type A is an immunobiological drug intended for emergency prevention and treatment of botulism caused by Clostridium botulinum toxin type A.
The serum is produced in Russia by Microgen NPO Allergen and Microgen NPO Immunopreparat. Belongs to the group of serums.
Manufacturers:
- Allergen (Stavropol, Russia)
- Microgen NPO (Allergen) (Russia)
- Microgen NPO (Immunopreparat) (Russia)
International name: Antibotulinum serum type A
Dosage forms:
- suspension for intramuscular administration 10,000 IU in 1 dose in an ampoule
The serum is administered intramuscularly after preliminary administration of 0.1 ml of the drug subcutaneously to exclude an anaphylactic reaction. The recommended dose for adults and children over 12 years of age is 20,000-100,000 IU, for children under 12 years of age - 5,000-20,000 IU.